Literature DB >> 35119547

Inflammation in Hepatocellular Carcinoma Patients Undergoing Hepatectomy: An Important Target for Ongoing Study : Editorial Comment on "The Impact of Histological Liver Inflammation on Oncology and the Prognosis of Patients Undergoing Hepatectomy for Hepatocellular Carcinoma".

June S Peng1, Niraj J Gusani2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35119547     DOI： 10.1245/s10434-022-11334-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Authors:  Richard S Finn; Shukui Qin; Masafumi Ikeda; Peter R Galle; Michel Ducreux; Tae-You Kim; Masatoshi Kudo; Valeriy Breder; Philippe Merle; Ahmed O Kaseb; Daneng Li; Wendy Verret; Derek-Zhen Xu; Sairy Hernandez; Juan Liu; Chen Huang; Sohail Mulla; Yulei Wang; Ho Yeong Lim; Andrew X Zhu; Ann-Lii Cheng
Journal:  N Engl J Med       Date:  2020-05-14       Impact factor: 91.245

2.  The Impact of Histologic Liver Inflammation on Oncology and the Prognosis of Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.

Authors:  Tatsunori Miyata; Hiromitsu Hayashi; Yo-Ichi Yamashita; Kazuki Matsumura; Takaaki Higashi; Katsunori Imai; Hidetoshi Nitta; Akira Chikamoto; Toru Beppu; Hideo Baba
Journal:  Ann Surg Oncol       Date:  2021-09-30       Impact factor: 5.344

Review 3.  Advances in immunotherapy for hepatocellular carcinoma.

Authors:  Bruno Sangro; Pablo Sarobe; Sandra Hervás-Stubbs; Ignacio Melero
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-04-13       Impact factor: 73.082
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.